The NOTCH1/CD39 axis: a Treg trip-switch for GvHD-Reference-Cited by-同舟云学术

The NOTCH1/CD39 axis: a Treg trip-switch for GvHD

Published:2016-04-29 Issue:9 Volume:30 Page:1931-1934
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Del Papa B,Pierini A,Sportoletti P,Baldoni S,Cecchini D,Rosati E,Dorillo E,Aureli P,Zei T,Iacucci Ostini R,Ruggeri L,Carotti A,Velardi A,Negrin R,Martelli M F,Falzetti F,Di Ianni M

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu201687.pdf

Reference21 articles.

1. Edinger M, Hoffmann P, Ermann J, Drago K, Fathman CG, Strober S et al. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 2003; 9: 1144–1150.

2. Sakaguchi S . Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22: 531–562.

3. Di Ianni M, Falzetti F, Carotti A, Terenzi A, Castellino F, Bonifacio E et al. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 2011; 117: 3921–3928.

4. Martelli MF, Di Ianni M, Ruggeri L, Falzetti F, Carotti A, Terenzi A et al. HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse. Blood 2014; 124: 638–644.

5. Di Ianni M, Falzetti F, Carotti A, Terenzi A, Del Papa B, Perruccio K et al. Immunoselection and clinical use of T regulatory cells in HLA haploidentical stem cell transplantation. Best Pract Res Clin Haematol 2011; 24: 459–466.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation;Cells;2024-01-11

2. Dissecting the regulatory network of transcription factors in T cell phenotype/functioning during GVHD and GVT;Frontiers in Immunology;2023-06-27

3. NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models;Bone Marrow Transplantation;2021-04-19

4. A single‐nucleotide polymorphism in the human ENTPD1 gene encoding CD39 is associated with worsened graft‐ versus ‐host disease in a humanized mouse model;Immunology & Cell Biology;2020-04-16

5. Human ectoenzyme-expressing ILC3: immunosuppressive innate cells that are depleted in graft-versus-host disease;Blood Advances;2019-11-21